COMPUGEN LTD — Investor Relations & Filings
Filings indexed
556
across all filing types
Latest filing
2026-03-26
Regulatory Filings
Country
US
United States of America
Listing
US
CGEN
Compugen Ltd. is a clinical-stage therapeutic discovery and development company focused on cancer immunotherapy. The company utilizes a proprietary, predictive computational platform powered by artificial intelligence and machine learning to systematically identify novel drug targets and biological pathways. This technology enables the discovery and development of first-in-class and best-in-class therapeutics. Compugen's pipeline consists of immuno-oncology programs, including antibody-based product candidates, which are advanced through preclinical and clinical development stages.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 144 - COMPUGEN LTD (0001119774) (Subject) | 2026-03-26 | English | |
| 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | |
| 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | |
| 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | |
| 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | |
| 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 33049795 | 144 - COMPUGEN LTD (0001119774) (Subject) | 2026-03-26 | English | ||
| 32972774 | 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | ||
| 32973927 | 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | ||
| 32973751 | 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | ||
| 32972842 | 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | ||
| 32972825 | 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | ||
| 32887767 | 20-F - COMPUGEN LTD (0001119774) (Filer) | 2026-03-02 | English | ||
| 27960311 | 6-K Filing | 2026-02-12 | English | ||
|
2025
7 filings
| |||||
| 11348906 | 6-K | 2025-12-17 | English | ||
| 11348907 | 6-K | 2025-11-10 | English | ||
| 11349023 | 6-K | 2025-10-14 | English | ||
| 11348908 | 6-K | 2025-09-17 | English | ||
| 11348909 | 6-K | 2025-08-06 | English | ||
| 11348918 | 6-K | 2025-08-06 | English | ||
| 11348922 | 6-K | 2025-07-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Bonus BioGroup Ltd.
A clinical-stage biotech firm developing cell therapy and t…
|
BONS | IL | Professional, scientific and te… |
|
BPH GLOBAL LTD
Biotech firm focused on plant-based health products and fun…
|
BP8 | AU | Professional, scientific and te… |
|
BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical,…
|
BNN | DE | Professional, scientific and te… |
|
BriaCell Therapeutics Corp.
Clinical-stage immuno-oncology company developing cellular …
|
BCTX | CA | Professional, scientific and te… |
|
Bright Minds Biosciences Inc.
Developing innovative serotonin-based drugs for neurologica…
|
DRUG | CA | Professional, scientific and te… |
|
BRIM Biotechnology, Inc.
Develops therapies for ophthalmology and degenerative disea…
|
6885 | TW | Professional, scientific and te… |
|
BSF ENTERPRISE PLC
Develops cell-based solutions for cultivated meat, leather,…
|
BSFA | GB | Professional, scientific and te… |
|
BullFrog AI Holdings, Inc.
A technology company applying AI and machine learning to dr…
|
BFRG | US | Professional, scientific and te… |
|
Burning Rock Biotech Ltd
A global diagnostics company specializing in precision onco…
|
BNR | US | Professional, scientific and te… |
|
Cabaletta Bio, Inc.
Develops engineered T cell therapies for B cell-mediated au…
|
CABA | US | Professional, scientific and te… |
COMPUGEN LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33979/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33979 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33979 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33979 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33979}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for COMPUGEN LTD (id: 33979)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.